All Relations between Alzheimer Disease and Neurodegenerative Diseases

Reference Sentence Publish Date Extraction Date Species
\\xc5\\x9eenay G\\xc3\\xb6r\\xc3\\xbcc\\xc3\\xbc Y\\xc4\\xb1lmaz, Salam Almasri, Yasemin Yuyucu Karabulut, Murat Korkmaz, \\xc3\\x96znur Bucak, Sibel O\\xc4\\x9fuzkan Balc\\xc4\\xb. Okadaic Acid-Induced Alzheimer's in Rat Brain: Phytochemical Cucurbitacin E Contributes to Memory Gain by Reducing TAU Protein Accumulation. Omics : a journal of integrative biology vol issue 2023 36594931 alzheimer's disease (ad) is a neurodegenerative disease characterized by progressive memory loss and cognitive decline, with hallmark pathologies related to amyloid beta (a\xce\xb2) and tau. 2023-01-03 2023-01-05 Not clear
Anna Atlante, Giuseppina Amadoro, Valentina Latina, Daniela Valent. Therapeutic Potential of Targeting Mitochondria for Alzheimer's Disease Treatment. Journal of clinical medicine vol 11 issue 22 2022 36431219 alzheimer's disease (ad), a chronic and progressive neurodegenerative disease, is characterized by memory and cognitive impairment and by the accumulation in the brain of abnormal proteins, more precisely beta-amyloid (\xce\xb2-amyloid or a\xce\xb2) and tau proteins. 2022-11-26 2022-11-28 Not clear
Mehboob Hoque, Arijit Samanta, Syed Sahajada Mahafujul Alam, Torki A Zughaibi, Mohammad Amjad Kamal, Shams Tabre. Nanomedicine-based immunotherapy for Alzheimer's Disease. Neuroscience and biobehavioral reviews vol issue 2022 36435391 alzheimer's disease (ad) is the most prevalent neurodegenerative disease caused by the deposition of amyloid \xce\xb2 (a\xce\xb2) fibrils forming extracellular plaques and the development of neurofibrillary tangles (nft) of intracellular hyperphosphorylated tau protein. 2022-11-26 2022-11-28 Not clear
Xiaoying Chen, David M Holtzma. Emerging roles of innate and adaptive immunity in Alzheimer's disease. Immunity vol issue 2022 36351425 alzheimer's disease (ad) is the most common neurodegenerative disease, with characteristic extracellular amyloid-\xce\xb2 (a\xce\xb2) deposition and intracellular accumulation of hyperphosphorylated, aggregated tau. 2022-11-09 2022-11-15 Not clear
E A Kovalenko, E V Makhnovich, N A Osinovskaya, A N Bogolepov. [Focused ultrasound as a non-invasive method with therapeutic potential in patients with Alzheimer's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova vol 122 issue 10 2022 36279227 alzheimer's disease (ad) is a common, progressive neurodegenerative disease characterized by abnormal deposition of \xce\xb2-amyloid (a\xce\xb2) and hyperphosphorylated tau protein. 2022-10-24 2022-11-01 Not clear
Wei Xiong, Ye Liu, Heng Zhou, Shuili Jing, Yan He, Qingsong Y. Alzheimer's disease: Pathophysiology and dental pulp stem cells therapeutic prospects. Frontiers in cell and developmental biology vol 10 issue 2022 36187488 alzheimer's disease (ad) is a destructive neurodegenerative disease with the progressive dysfunction, structural disorders and decreased numbers of neurons in the brain, which leads to long-term memory impairment and cognitive decline. 2022-10-03 2022-10-10 Not clear
Gemma Shireby, Emma L Dempster, Stefania Policicchio, Rebecca G Smith, Ehsan Pishva, Barry Chioza, Jonathan P Davies, Joe Burrage, Katie Lunnon, Dorothea Seiler Vellame, Seth Love, Alan Thomas, Keeley Brookes, Kevin Morgan, Paul Francis, Eilis Hannon, Jonathan Mil. DNA methylation signatures of Alzheimer's disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types. Nature communications vol 13 issue 1 2022 36153390 alzheimer's disease (ad) is a chronic neurodegenerative disease characterized by the progressive accumulation of amyloid-beta and neurofibrillary tangles of tau in the neocortex. 2022-09-24 2022-09-29 Not clear
Javad Sharifi-Rad, Simona Rapposelli, Simona Sestito, Jes\\xc3\\xbas Herrera-Bravo, Alejandra Arancibia-Diaz, Luis A Salazar, Balakyz Yeskaliyeva, Ahmet Beyatli, Gerardo Leyva-G\\xc3\\xb3mez, Carlos Gonz\\xc3\\xa1lez-Contreras, Eda S\\xc3\\xb6nmez G\\xc3\\xbcrer, Miquel Martorell, Daniela Calin. Multi-Target Mechanisms of Phytochemicals in Alzheimer's Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation. Journal of personalized medicine vol 12 issue 9 2022 36143299 alzheimer's disease (ad) is a neurodegenerative disease characterized by a tangle-shaped accumulation of beta-amyloid peptide fragments and tau protein in brain neurons. 2022-09-23 2022-09-29 Not clear
Keren Wood, Idit Maharshak, Yosef Koronyo, Maya Koronyo-Hamaou. [THE RETINA AS A TOOL FOR EARLY DIAGNOSIS OF ALZHEIMER DISEASE]. Harefuah vol 161 issue 8 2022 35979573 alzheimer's disease is a neurodegenerative disease pathologically characterized by accumulation of abnormal amyloid-beta (a\xce\xb2) and tau proteins. 2022-08-18 2022-08-22 Not clear
Eva Baerends, Katia Soud, Jonas Folke, Anna-Kathrine Pedersen, Simon Henmar, Lisa Konrad, Matthew D Lycas, Yuki Mori, Bente Pakkenberg, David P D Woldbye, Oksana Dmytriyeva, Stanislava Pankratov. Modeling the early stages of Alzheimer's disease by administering intracerebroventricular injections of human native A\\xce\\xb2 oligomers to rats. Acta neuropathologica communications vol 10 issue 1 2022 35974377 alzheimer's disease (ad) is a progressive and irreversible neurodegenerative disease characterized by the accumulation of aggregated amyloid beta (a\xce\xb2) and hyperphosphorylated tau along with a slow decline in cognitive functions. 2022-08-16 2022-08-22 Not clear
Juan Li, Bin Zou, Xiao-Yu Cheng, Xin-He Yang, Jia Li, Chun-Hui Zhao, Rui-Xia Ma, Ji-Xiang Tian, Yao Ya. Therapeutic effects of total saikosaponins from Frontiers in pharmacology vol 13 issue 2022 35935875 therapeutic effects of total saikosaponins from alzheimer's disease (ad) is a neurodegenerative disease characterized by memory loss and cognitive dysfunction in the elderly, with amyloid-beta (a\xce\xb2) deposition and hyperphosphorylation of tau protein as the main pathological feature. 2022-08-08 2022-08-15 Not clear
Hu Zhang, Jiling Liang, Ning Che. The Potential Role of miRNA-Regulated Autophagy in Alzheimer's Disease. International journal of molecular sciences vol 23 issue 14 2022 35887134 as a neurodegenerative disease, alzheimer's disease (ad) shows a higher incidence during the aging process, mainly revealing the characteristics of a significant decrease in cognition, uncontrolled emotion, and reduced learning and memory capacity, even leading to death. 2022-07-27 2022-08-08 Not clear
Alexandria B Marciante, John Howard, Mia N Kelly, Juan Santiago Moreno, Latoya L Allen, Elisa J Gonzalez-Rothi, Gordon S Mitchel. Dose-dependent Phosphorylation of Endogenous Tau by Intermittent Hypoxia in Rat Brain. Journal of applied physiology (Bethesda, Md. : 1985) vol issue 2022 35861520 sleep apnea is comorbid in >50% of patients with alzheimer's disease-a progressive, neurodegenerative disease associated with brain amyloid and chronic tau dysregulation (pathology). 2022-07-21 2022-07-25 Not clear
Cong Li. The Role of Mesenchymal Stem Cells in Regulating Astrocytes-Related Synapse Dysfunction in Early Alzheimer's Disease. Frontiers in neuroscience vol 16 issue 2022 35801178 alzheimer's disease (ad), a neurodegenerative disease, is characterized by the presence of extracellular amyloid-\xce\xb2 (a\xce\xb2) aggregates and intracellular neurofibrillary tangles formed by hyperphosphorylated tau as pathological features and the cognitive decline as main clinical features. 2022-07-08 2022-07-11 Not clear
S Tok, H Maurin, C Delay, D Crauwels, N V Manyakov, W Van Der Elst, D Moechars, W H I M Drinkenbur. Neurophysiological effects of human-derived pathological tau conformers in the APPKM670/671NL.PS1/L166P amyloid mouse model of Alzheimer's disease. Scientific reports vol 12 issue 1 2022 35546164 alzheimer's disease (ad) is a neurodegenerative disease characterized by two main pathological hallmarks: amyloid plaques and intracellular tau neurofibrillary tangles. 2022-05-13 2022-06-13 Not clear
Yongle Cai, Jingliu Liu, Bin Wang, Miao Sun, Hao Yan. Microglia in the Neuroinflammatory Pathogenesis of Alzheimer's Disease and Related Therapeutic Targets. Frontiers in immunology vol 13 issue 2022 35558075 alzheimer's disease (ad) is the most prevalent neurodegenerative disease worldwide, characterized by progressive neuron degeneration or loss due to excessive accumulation of \xce\xb2-amyloid (a\xce\xb2) peptides, formation of neurofibrillary tangles (nfts), and hyperphosphorylated tau. 2022-05-13 2022-06-13 Not clear
Joubin Jebelli, Michael C Hamper, Danielle Van Quelef, Davian Caraballo, James Hartmann, James Kumi-Diak. The Potential Therapeutic Effects of Low-Dose Ionizing Radiation in Alzheimer's Disease. Cureus vol 14 issue 3 2022 35371871 alzheimer's is classified as a progressive, debilitating neurodegenerative disease that results in disturbances to a patient's higher executive function, memory, language, and visuospatial orientation. 2022-04-04 2022-04-14 Not clear
Filipa Gouveia, Antoni Camins, Miren Ettcheto, Joana Bicker, Am\\xc3\\xadlcar Falc\\xc3\\xa3o, M Teresa Cruz, Ana Fortun. Targeting Brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: past, present and future. Ageing research reviews vol issue 2022 35346852 alzheimer's disease (ad) is a well-known neurodegenerative disease characterized by the presence of two main hallmarks - tau hyperphosphorylation and a\xce\xb2 deposits. 2022-03-29 2022-04-14 Not clear
Min Cao, Jing Liu, Xiaomin Zhang, Tingting Yang, Yaqi Wang, Yuli Hou, Qiao Song, Yuting Cui, Yifei Wang, Peichang Wan. ABI3 Is a Novel Early Biomarker of Alzheimer's Disease. Journal of Alzheimer's disease : JAD vol issue 2022 35275543 the abi3 gene has been suggested to be an important regulator of microglia during alzheimer's disease (ad), but the diagnostic power of abi3 in neurodegenerative disease has rarely been reported. 2022-03-11 2022-04-14 Not clear
Thibaut Gauvrit, Hamza Benderradji, Luc Bu\\xc3\\xa9e, David Blum, Didier Viea. Early-Life Environment Influence on Late-Onset Alzheimer's Disease. Frontiers in cell and developmental biology vol 10 issue 2022 35252195 alzheimer disease (ad) which is the most prevalent neurodegenerative disease is mostly sporadic and primarily characterized by cognitive deficits and neuropathological lesions such as amyloid -\xce\xb2 (a\xce\xb2) plaques and neurofibrillary tangles composed of hyper- and/or abnormally phosphorylated tau protein. 2022-03-08 2022-03-09 Not clear
Page: 
1   2   3   4   5   6   7   8   9   10   11